Navigation Links
NORTHWEST BIO Will Present at the Second Annual "Cancer Immunotherapy: A Long Awaited Reality Conference" at the New York Academy of Medicine, October 6, 2011
Date:10/4/2011

BETHESDA, Md., Oct. 4, 2011 /PRNewswire/ -- Northwest Biotherapeutics (OTC.BB: NWBO) (NORTHWEST BIO) today announced that it will be presenting at the second annual Cancer Immunotherapy: A Long-Awaited Reality Conference on Thursday, October 6, at the New York Academy of Medicine in New York City.  The single-day conference unites key opinion leaders, industry executives, and other stakeholders to engage in discussions, exchange information, and highlight opportunities in the field of cancer immunotherapy that is now coming of age.

Dr. Anthony Maida, COO, and Mr. Leslie J. Goldman, Sr. Vice President for Business Development, of NORTHWEST BIO will be making the presentation. They will be presenting the science of DCVax®, the promising clinical data generated to date, and the progress of the Company's pipeline of multiple individualized cancer vaccine products.  They will indicate how NORTHWEST BIO's developing immunotherapy products hold the promise of treating cancers more effectively than the current standard of care, without toxicities of the kind associated with chemotherapies, and on a cost-effective basis, in both the US and Europe.

Ms. Linda Powers, CEO of NORTHWEST BIO said, "This topic and conference are particularly timely in view of yesterday's Nobel Prize in Medicine for certain key discoveries about the immune system – especially about the critical role of dendritic cells.  At NORTHWEST BIO, we have developed medical treatments for cancer using these same dendritic cells, whose discovery by Dr. Ralph Steinman now has earned the Nobel Prize.  Our medical treatments are one of the first personalized medicines to apply this potential: they make use of the patient's own dendritic cells, which are activated and "educated" to mobilize the immune system to attack that patient's particular cancer." 

"We have been developing these dendritic cell treatments for over a decade and have now reached late s
'/>"/>

SOURCE Northwest Biotherapeutics
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Family Foundation of Business Leader Invests $4.55 Million in Northwest Biotherapeutics for Promising Clinical Trials in the US and Europe
2. Cord Blood America Enters Agreement With Regence, Serving BlueCross and BlueShield Programs in the Northwest U.S. and Mountain Regions
3. Dendreon CEO Dr. Mitchell Gold Named Ernst & Young Entrepreneur Of The Year® 2011 Pacific Northwest Award Winner
4. Northwest Biotherapeutics Announces Change and Expansion of Management Team
5. Northwest Biotherapeutics Announces Series of Financing Arrangements
6. Northwest Biotherapeutics to Present at American Society of Cell and Gene Therapy
7. Northwest Biotherapeutics and the Fraunhofer Institute for Cell Therapy and Immunology are Partnering for Clinical Trials and Compassionate Use Cases in Europe
8. Northwest Biotherapeutics Addresses Recent Market Activity
9. Cell Therapeutics, Inc. (CTI) to Present at Life Science Innovation Northwest
10. Registration Open for WBBAs Life Science Innovation Northwest 2011 Event Webcast
11. BioSpace Highlights the Northwests Growing Life Science Region
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/14/2014)... EquitiesIQ, a leading informational research provider, has ... an emerging biomedical company acquiring, developing, manufacturing, and marketing ... Free report download: http://equitiesiq.com/reports/alliqua/ , In late ... and Board, which launched the company’s new strategy to ...
(Date:1/14/2014)... January 14, 2014 In recent years, ... and methods in product development and promotion has led ... This mistrust, fueled by concerns about the insidious impact ... reports of spectacular fines to the world’s biggest pharmas ...
(Date:1/14/2014)... Cardiff, UK (PRWEB) January 13, 2014 ... leader with more than 20 years in the industry, ... and photonics . Hainsey will serve as the society’s ... have Dr. Hainsey join SPIE as our Technology Strategist, ...
(Date:1/14/2014)... Triangle Park, NC (PRWEB) January 14, 2014 ... company focusing on ultra-sensitive POC diagnostic platforms and novel disease ... their first round of financing netting a total of $690,000. ... outside equity capital in the company. This group of private ...
Breaking Biology Technology:EquitiesIQ Initiates Coverage of Alliqua, Inc. 2EquitiesIQ Initiates Coverage of Alliqua, Inc. 3The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 2The Sunshine Act: Necessary Regulation or Unnecessary Dysregulation? New Life Science Webinar Hosted by Xtalks and IRB Services 3Photonics R&D Leader Bob Hainsey Joins SPIE Technical Staff 2BioMedomics, Inc. Closes $690K Round of Financing 2
... Focus on Critical Industry Issues -- DUBAI, UAE, September 8, 2010 ... ... ... keyed by longUrl, so we need to grab the first one. for (var r in data.results) { first_result ...
... YORK, Sept. 7 Reportlinker.com announces that a ... catalogue: Biotechnology Pharmaceutical Market in ... Biotechnology Pharmaceutical Market in US ... Pharmaceutical market to grow at a CAGR of ...
... Inc. (OTC Bulletin Board: FCSC ), a ... therapies for aesthetic, medical and scientific applications, announced today ... to its scientific advisory board. In addition to being ... a biotechnology and genetic research expert. Dr. Gruenwald also ...
Cached Biology Technology:Cold Chain MENA 2010 to Focus on Critical Industry Issues 2Cold Chain MENA 2010 to Focus on Critical Industry Issues 3Cold Chain MENA 2010 to Focus on Critical Industry Issues 4Cold Chain MENA 2010 to Focus on Critical Industry Issues 5Cold Chain MENA 2010 to Focus on Critical Industry Issues 6Reportlinker Adds Biotechnology Pharmaceutical Market in US -2013 2Fibrocell Science, Inc. Names Biotechnology and Genetic Research Expert Stefan Gruenwald, M.D., Ph.D., to Scientific Advisory Board 2Fibrocell Science, Inc. Names Biotechnology and Genetic Research Expert Stefan Gruenwald, M.D., Ph.D., to Scientific Advisory Board 3
(Date:4/23/2014)... TX (4/23/14) -- Researchers have found evidence of ... factors that increase aggressive behavior in children, especially ... not all children exposed to prenatal smoking will ... will not," said Brian Boutwell, Assistant Professor at ... and senior author on the study. "One ...
(Date:4/23/2014)... away from using triclosan as an antimicrobial ingredient in ... now scientists are reporting new evidence that appears to ... journal Chemical Research in Toxicology , found that ... promoted the growth of human breast cancer cells in ... Kyung-Chul Choi and colleagues note that hormonal imbalances seem ...
(Date:4/23/2014)... comprehensive study to date of the family of ... effective vaccine strategies and reveals surprising findings about ... could alter public health strategies to control this ... year. , Genomic analysis of 343 strains of ... the world collected over the last 100 years ...
Breaking Biology News(10 mins):Genetics risk, prenatal smoking may predict behavioral problems 2In lab tests, the antimicrobial ingredient triclosan spurs growth of breast cancer cells 2Impact of whooping cough vaccination revealed 2
... Scheduling more physical education time in schools does not ... research that discovered those who got lots of timetabled ... while those who got little at school made up ... The scientists, who presented their research Thursday at the ...
... Inc. (Nasdaq: AWRE ), a leading supplier of ... its first quarter ended March 31, 2009. Revenues for ... of 22% compared to $5.9 million in the same quarter ... and diluted net income per share in accordance with U.S. ...
... Desert environments are characterized by poor vegetative cover, ... conditions. In this context, the land resources of ... are subjected to various land degradation stresses, including ... sustain the land resources of Abu Dhabi Emirate, ...
Cached Biology News:Study finds children's activity levels not influenced by more PE time in school 2Aware, Inc. Reports First Quarter 2009 Financial Results 2Aware, Inc. Reports First Quarter 2009 Financial Results 3Aware, Inc. Reports First Quarter 2009 Financial Results 4Aware, Inc. Reports First Quarter 2009 Financial Results 5Aware, Inc. Reports First Quarter 2009 Financial Results 6Wind, salt and water are leading indicators of land degradation in Abu Dhabi 2
...
Human Cystatin A MAb (Clone 224705)...
Corticoliberin...
Anti-SDF-1β/PBSF affinity isolated antibody lyophilized powder Lyophilized from a 0.2 μm filtered solution in phosphate buffered saline recombinant human SDF-1β/PBSF expressed in E....
Biology Products: